WO1997040008A1 - Procede de preparation de derives pyrrolidiniques - Google Patents
Procede de preparation de derives pyrrolidiniques Download PDFInfo
- Publication number
- WO1997040008A1 WO1997040008A1 PCT/JP1997/001373 JP9701373W WO9740008A1 WO 1997040008 A1 WO1997040008 A1 WO 1997040008A1 JP 9701373 W JP9701373 W JP 9701373W WO 9740008 A1 WO9740008 A1 WO 9740008A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- group
- general formula
- salt
- diphenylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
Definitions
- the present invention provides a compound represented by the following general formula (2), which is useful as an intermediate for the synthesis of chemicals such as pharmaceuticals and fistulas:
- R is a 1,1-diphenylmethyl group, a 1-dibromomethyl-1.1.1 diphenylmethyl group, an n-butylyloxy group, a methansulfonyloxy group, or , P-toluenesulfonyloxy group.
- a method for debenzylating 1-benzyl-3-ylmethanesulfonyloxypyrrolidine to produce 3-methanesulfonyloxypyrrolidine or a salt thereof and a method for producing 1-benzyl-3yl-p-toluenesulfonyloxy
- a method for producing 3--toluenesulfonyloxypyrrolidine or a salt thereof by removing benzyl from pyrrolidine; and 1 removing benzyl from 3 -n-butylyloxypiperidine, 3 -n —A method for producing butyryloxypyrrolidine or a salt thereof is not known.
- an object of the present invention is to provide a method for producing a pyrrolidine derivative represented by the general formula (2) or a salt thereof in a simple, economical, highly productive, and high yield. Is what you do.
- the present invention provides the following one-pronged type (1):
- R is the same as described above
- hydrochloric acid sulfuric acid, phosphoric acid, p-toluenesulfonic acid, methanesulfonic acid, acetic acid, n-butyric acid, trifluorosulfonic acid, And at least one selected from the group consisting of oxalic acid
- the compound represented by the general formula (1) used in the present invention includes, for example, Japanese Unexamined Patent Application Publication No. Sho 61-1-100563, Japanese Unexamined Patent Application Publication No. Hei 1-113365, Japanese Unexamined Patent Application Publication No. Hei 1-1141600, Japanese Unexamined Patent Publication No. Hei 11-143 It can be produced by the method described in JP-A-852-2.
- the protonic acid used in the present invention is selected from the group consisting of hydrochloric acid, sulfuric acid, phosphoric acid, p-toluenesulfonic acid, methanesulfonic acid, acetic acid, ⁇ -harsh acid, trifluoroacetic acid, and oxalic acid. At least one species. Of these, hydrochloric acid, sulfuric acid, and oxalic acid are preferred.
- the amount of the above-mentioned protonic acid to be used may be about 1 equivalent to the compound represented by the above-mentioned general formula (1) as a starting material.
- the above-mentioned protonic acid may be charged together with the compound represented by the above-mentioned general formula (1) as a starting material, a reaction solvent, and a metal-to-medium. May be prepared and charged together with a reaction solvent and a metal catalyst.
- metal catalyst used in the present invention examples include ruthenium, rhodium, platinum, palladium and the like. These may be used alone or in combination of two or more. These may be used alone or in a form supported by activated carbon, but it is preferable to use palladium carbon.
- the use amount of the metal catalyst is preferably 0.001 to 20% by weight based on the compound represented by the general formula (1). More preferably, it is 0.1 to 5% by weight.
- reaction solvent examples include alcohols such as methanol, ethanol, n-propanol, and isopropanol; hydrogen fluorides such as benzene, toluene, and cyclohexane; getyl ether, tetrahydrofuran; Ethers such as dioxane; esters such as ethyl acetate and butyl acetate; organic solvents such as methylene chloride and dimethylformamide; water and the like. be able to. These may be used alone or in combination of two or more. Among them, it is preferable to use alcohols or a mixed solvent of alcohols and water.
- the use amount of the above reaction solvent is preferably 0.1 to 10 times the compound represented by the above general formula (1). It is more preferably 0.3 to 3 times, and even more preferably 0.3 to 1.5 times.
- the reaction temperature of the above reaction is preferably from 0 to 100, more preferably
- the hydrogen pressure is preferably in the range of normal pressure to 300 kPa which can be arbitrarily set according to the equipment used.
- the pyrrolidine derivative represented by the general formula (2) or a salt thereof is racemic as a corresponding optically active substance. Can be obtained without conversion.
- the optically active form of the pyrrolidine derivative represented by the general formula (2) or a salt thereof include (S) -3- (1-cyano-1,1-diphenylmethyl) -pyrrolidine.
- the compound represented by the general formula (1) is hydrocracked using the metal catalyst in the presence of the protonic acid, A pyrrolidine derivative represented by the general formula (2) or a salt thereof can be obtained.
- Examples of the salt of the pyrrolidine derivative include a salt of protic acid during the reaction and a salt with another acid.
- the synthesized pyrrolidine ⁇ conductor represented by the above general formula (2) or a salt thereof is separated from the reaction-terminated liquid by a method such as filtration or centrifugation to separate a metal catalyst, and then is subjected to a concentration method generally used. It can be isolated and purified as a free form or as a salt with protic acid by a processing method such as solvent extraction, distillation and crystallization. * Good form for carrying out the invention
- Example 1
- the reaction solution was taken out, the toluene solution and water were added to an oily substance obtained by concentrating the rapa solution obtained by separating the catalyst under reduced pressure, and 30% aqueous sodium hydroxide was added dropwise with stirring in an ice water bath. pH 13 was set.
- the toluene layer was collected, the aqueous layer was further extracted with toluene, and the toluene layers were combined, washed with saturated saline, and dried over anhydrous sodium sulfate. After drying with helium, filtration, concentration under reduced pressure, and further vacuum drying, (S) -3- (1-cyano-1,1-diphenylmethyl) -pyrrolidine 2.1 was obtained as an oil (yield 9 1 mol%).
- Dichloromethane was added to 2.0 g of the obtained (R, S) -3-n-butyryloxypyrrolidine hydrochloride, and the mixture was basified by dropwise addition of saturated aqueous sodium hydrogen carbonate under cooling in an ice-water bath. The dichloromethane layer was collected, the aqueous layer was further extracted with dichloromethane, and the dichloromethane layers were combined, washed with brine, dried over anhydrous sodium sulfate, concentrated after filtration, and concentrated under reduced pressure (R, S). 1.2 g of 3 — n-butyliloxyvirolidine was obtained.
- a 3-substituted pyrrolidine derivative or a salt thereof which is useful as a synthetic intermediate for chemicals such as medical products and agricultural chemicals, can be produced simply, economically, with good productivity, and with high yield. Can be manufactured.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/171,996 US6005119A (en) | 1996-04-22 | 1997-04-22 | Process for preparing pyrrolidine derivatives |
EP97917456A EP0900787B1 (en) | 1996-04-22 | 1997-04-22 | Process for preparing pyrrolidine derivatives |
DE69715402T DE69715402T2 (de) | 1996-04-22 | 1997-04-22 | Verfahren zur herstellung von pyrrolidin-derivaten |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12636196 | 1996-04-22 | ||
JP8/126361 | 1996-04-22 | ||
JP01463997A JP4057088B2 (ja) | 1996-04-22 | 1997-01-09 | ピロリジン誘導体の製造方法 |
JP9/14639 | 1997-01-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997040008A1 true WO1997040008A1 (fr) | 1997-10-30 |
Family
ID=26350627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/001373 WO1997040008A1 (fr) | 1996-04-22 | 1997-04-22 | Procede de preparation de derives pyrrolidiniques |
Country Status (6)
Country | Link |
---|---|
US (1) | US6005119A (ja) |
EP (1) | EP0900787B1 (ja) |
JP (1) | JP4057088B2 (ja) |
DE (1) | DE69715402T2 (ja) |
ES (1) | ES2183160T3 (ja) |
WO (1) | WO1997040008A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007011162A1 (en) * | 2005-07-20 | 2007-01-25 | Chiroad Incorporate | Synthetic method of optically pure (s)-3-hydroxypyrrolidine |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100395779B1 (ko) * | 2001-05-25 | 2003-08-21 | 한국화학연구원 | 임의적으로 베타-위치가 치환된 알파-아릴알킬기의 제거를통해 3급 아미드 화합물로부터 2급 아미드 화합물을제조하는 방법 |
JP5450387B2 (ja) | 2008-04-02 | 2014-03-26 | 株式会社カネカ | (s)−3−(1−シアノ−1,1−ジフェニルメチル)−ピロリジンの製造法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61100563A (ja) * | 1984-10-19 | 1986-05-19 | エイ・エツチ・ロビンス・カンパニー・インコーポレーテツド | 1‐[(アミノアルキルおよびアミノアルキルアミノ)カルボニルおよびチオカルボニル]‐α,α‐ジアリールピロリジン、ピペリジンおよびホモピペリジンアセトアミドおよびアセトニトリル |
JPS62169763A (ja) * | 1986-01-17 | 1987-07-25 | エイ・エイチ・ロビンス・カンパニー・インコーポレーテッド | 心血管薬、抗ヒスタミン薬および分泌抑制薬としてのn−置換−アリ−ルアルキル−および−アリ−ルアルキレン−アミノ複素環化合物 |
JPS6341453A (ja) * | 1986-08-08 | 1988-02-22 | Tokyo Kasei Kogyo Kk | 3−(アシルアミノ)ピロリジン又はその塩の製造法 |
JPH02218664A (ja) * | 1989-02-17 | 1990-08-31 | Tokyo Kasei Kogyo Kk | 光学活性な1h−3−アミノピロリジン化合物の製造法 |
JPH03176463A (ja) * | 1989-12-02 | 1991-07-31 | Kanegafuchi Chem Ind Co Ltd | ピロリジノール誘導体およびその製法 |
JPH0495067A (ja) * | 1990-08-09 | 1992-03-27 | Fujisawa Pharmaceut Co Ltd | ピロリジン化合物の製造法 |
JPH0558995A (ja) * | 1991-09-04 | 1993-03-09 | Shionogi & Co Ltd | ピロリジン誘導体の製造法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4208423A (en) * | 1978-11-24 | 1980-06-17 | Syntex Inc. | Anticholinergic bronchodilators |
US4810703A (en) * | 1984-10-19 | 1989-03-07 | A. H. Robins Company, Incorporated | 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha, alpha-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles |
DE3501496A1 (de) * | 1985-01-18 | 1986-07-24 | Behringwerke Ag, 3550 Marburg | Verfahren zur bestimmung der aktivitaet des komplementsystems des blutes |
US4851418A (en) * | 1987-08-21 | 1989-07-25 | Warner-Lambert Company | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent |
FR2687146B1 (fr) * | 1992-02-12 | 1994-04-01 | Adir Cie | Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-01-09 JP JP01463997A patent/JP4057088B2/ja not_active Expired - Fee Related
- 1997-04-22 ES ES97917456T patent/ES2183160T3/es not_active Expired - Lifetime
- 1997-04-22 EP EP97917456A patent/EP0900787B1/en not_active Expired - Lifetime
- 1997-04-22 US US09/171,996 patent/US6005119A/en not_active Expired - Lifetime
- 1997-04-22 DE DE69715402T patent/DE69715402T2/de not_active Expired - Lifetime
- 1997-04-22 WO PCT/JP1997/001373 patent/WO1997040008A1/ja active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61100563A (ja) * | 1984-10-19 | 1986-05-19 | エイ・エツチ・ロビンス・カンパニー・インコーポレーテツド | 1‐[(アミノアルキルおよびアミノアルキルアミノ)カルボニルおよびチオカルボニル]‐α,α‐ジアリールピロリジン、ピペリジンおよびホモピペリジンアセトアミドおよびアセトニトリル |
JPS62169763A (ja) * | 1986-01-17 | 1987-07-25 | エイ・エイチ・ロビンス・カンパニー・インコーポレーテッド | 心血管薬、抗ヒスタミン薬および分泌抑制薬としてのn−置換−アリ−ルアルキル−および−アリ−ルアルキレン−アミノ複素環化合物 |
JPS6341453A (ja) * | 1986-08-08 | 1988-02-22 | Tokyo Kasei Kogyo Kk | 3−(アシルアミノ)ピロリジン又はその塩の製造法 |
JPH02218664A (ja) * | 1989-02-17 | 1990-08-31 | Tokyo Kasei Kogyo Kk | 光学活性な1h−3−アミノピロリジン化合物の製造法 |
JPH03176463A (ja) * | 1989-12-02 | 1991-07-31 | Kanegafuchi Chem Ind Co Ltd | ピロリジノール誘導体およびその製法 |
JPH0495067A (ja) * | 1990-08-09 | 1992-03-27 | Fujisawa Pharmaceut Co Ltd | ピロリジン化合物の製造法 |
JPH0558995A (ja) * | 1991-09-04 | 1993-03-09 | Shionogi & Co Ltd | ピロリジン誘導体の製造法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP0900787A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007011162A1 (en) * | 2005-07-20 | 2007-01-25 | Chiroad Incorporate | Synthetic method of optically pure (s)-3-hydroxypyrrolidine |
US7652152B2 (en) | 2005-07-20 | 2010-01-26 | Chiroad Incorporate | Synthetic method of optically pure (S)-3-hydroxypyrrolidine |
Also Published As
Publication number | Publication date |
---|---|
ES2183160T3 (es) | 2003-03-16 |
US6005119A (en) | 1999-12-21 |
EP0900787A1 (en) | 1999-03-10 |
EP0900787B1 (en) | 2002-09-11 |
DE69715402T2 (de) | 2003-08-07 |
JP4057088B2 (ja) | 2008-03-05 |
DE69715402D1 (de) | 2002-10-17 |
EP0900787A4 (en) | 1999-08-11 |
JPH107652A (ja) | 1998-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | L-DMDP, L-homoDMDP and their C-3 fluorinated derivatives: synthesis and glycosidase-inhibition | |
JPH07309834A (ja) | 鏡像体的に純粋なジアリールプロリノールの製造方法 | |
CH648314A5 (fr) | Procede de preparation de trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b)-indoles substitues en position 2 et composes permettant de les obtenir. | |
JPS603387B2 (ja) | 新規光学活性イミダゾリジン−2−オン誘導体およびその製法 | |
WO1997040008A1 (fr) | Procede de preparation de derives pyrrolidiniques | |
KR20010042750A (ko) | 거울상 이성질체-유리n-메틸-n-[(1s)-1-페닐-2-((3s)-3-히드록시피롤리딘-1-일)에틸]-2,2-디페닐아세트아미드의 제조 방법 | |
WO2007080470A2 (en) | A method for the purification of levetiracetam | |
KR100743617B1 (ko) | 고광학순도를 갖는 키랄 3-히드록시 피롤리딘 및 그유도체를 제조하는 방법 | |
JPS638368A (ja) | 4−ベンジロキシ−3−ピロリン−2−オン−1−イルアセトアミド、その製造方法および使用方法 | |
CN115403509A (zh) | 一种雷芬那辛中间体的制备方法 | |
JP2909145B2 (ja) | β―ラクタマーゼ抑止剤の製法 | |
JP2020070296A (ja) | リナグリプチンの製造法 | |
JPS6148839B2 (ja) | ||
JP2998154B2 (ja) | (2r.4r)−4−メチル−2−ピペリジンカルボン酸エチルエステルのl−酒石酸塩ならびに(2r.4r)−4−メチル−2−ピペリジンカルボン酸エチルエステルのl−酒石酸塩およびその脱塩体の製造法 | |
JP3274247B2 (ja) | 光学活性なインドリン誘導体の製法と中間体 | |
FI68830C (fi) | Dl- eller d-trans-8-fluor-5-(p-fluorfenyl)-2,3,4,4a,5,9b-heksahydro-1h-pyrido(4,3-b)indol som anvaends som mellanprodukt vid framstaellning av terapeutiskt anvaendbara 2-substituerade dl- och d-trans-8-fluor-5-(p-fluorfenyl)-2,3,4,4a,5,9b-heksahydro-1h-pyrido(4,3-b)indoler | |
WO2007035003A1 (ja) | 光学活性なピペラジン化合物の製造方法 | |
JPS6388184A (ja) | α―N―〔(ハイポキサンチン―9―イル)―ペンチルオキシカルボニル〕―アルギニンの製造方法 | |
JPH0418050A (ja) | (r)―2―ヒドロキシ―4―フェニル―3―ブテン酸の製造法 | |
FR2713642A1 (fr) | Procédé de préparation de l'épibatidine. | |
JPH07149729A (ja) | 1,2,3,4−テトラヒドロキノリン−8−スルホン酸およびそのクロリド体、それらの製法、並びに合成中間体としてのそれらの用途 | |
Wegner et al. | Perhydrogenation of 2, 8-diaminopurine | |
KR20010099122A (ko) | 무스콘 라세미체로부터 엘-무스콘 또는 디-무스콘을 분리정제하는 방법 | |
JPS63503384A (ja) | 1‐置換(s)‐および(r)‐2‐アミノメチルピロリジン類の有効な立体保存的合成およびその中間体 | |
JP3376886B2 (ja) | スポロクノールaの製造法およびその合成中間体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997917456 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997917456 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09171996 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997917456 Country of ref document: EP |